Ceribell (CBLL) Interest & Investment Income (2025 - 2026)
Ceribell's (CBLL) quarterly Interest & Investment Income came in at -$141000.0 in Q1 2026, down 2250.0% YoY from $6558.1 in Q1 2025, and down 805.0% on a QoQ basis from $20000.0 in Q4 2025.
Ceribell (CBLL) Interest & Investment Income (2025 - 2026) Analysis & Trends
Ceribell (CBLL) has 2 years of Interest & Investment Income data on file, last reported at -$141000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 2250.0% year-over-year to -$141000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24000.0 (changed N/A YoY) and the FY2025 annual result came in at $159000.0, changed N/A from the prior year.
- Interest & Investment Income slipped to -$141000.0 in Q1 2026, from $20000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $134000.0 in Q3 2025 to a low of -$141000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | - |
| 10 | Ceribell | 933.50 Mn | 804.23 Mn | 25.94 Mn | -110,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -110,000.00 |
| Mar 31, 2026 | -141,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | -6,000.00 |